T1	PROC 46 73	Seguimiento de la seguridad
#1	AnnotatorNotes T1	C5235447; Safety Monitoring; Research Activity
T2	DISO 103 138	tumor de células gigantes del hueso
#2	AnnotatorNotes T2	C0206638; Giant Cell Tumor of Bone; Neoplastic Process
T3	CHEM 152 161	denosumab
#3	AnnotatorNotes T3	C1690432; denosumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 139 147	tratados
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 208 222	Tumor de hueso
T6	ANAT 217 222	hueso
#5	AnnotatorNotes T6	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T7	DISO 249 284	tumor de células gigantes del hueso
#6	AnnotatorNotes T7	C0206638; Giant Cell Tumor of Bone; Neoplastic Process
T8	PROC 551 565	procedimientos
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T9	PROC 596 605	protocolo
#8	AnnotatorNotes T9	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T10	PROC 639 653	procedimientos
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	CHEM 746 755	denosumab
#10	AnnotatorNotes T11	C1690432; denosumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	PROC 828 842	anticoncepción
#11	AnnotatorNotes T12	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T13	PROC 854 865	tratamiento
#12	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 913 924	tratamiento
#13	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	ANAT 112 128	células gigantes
#14	AnnotatorNotes T15	C0017526; Giant Cells; Cell
T16	ANAT 133 138	hueso
#15	AnnotatorNotes T16	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T17	ANAT 258 274	células gigantes
#16	AnnotatorNotes T17	C0017526; Giant Cells; Cell
T18	ANAT 279 284	hueso
#17	AnnotatorNotes T18	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T19	Date 13 17	2017
T20	Date 74 87	a largo plazo
T21	LIVB 91 98	sujetos
#18	AnnotatorNotes T21	C0681850; Study Subject; Group
T22	LIVB 324 331	sujetos
#19	AnnotatorNotes T22	C0681850; Study Subject; Group
T23	LIVB 365 372	sujetos
#20	AnnotatorNotes T23	C0681850; Study Subject; Group
T24	LIVB 483 490	Sujetos
#21	AnnotatorNotes T24	C0681850; Study Subject; Group
T26	LIVB 703 715	investigador
#22	AnnotatorNotes T26	C0035173; Research Personnel; Professional or Occupational Group
T27	LIVB 719 741	Mujeres en edad fértil
#23	AnnotatorNotes T27	C4324275; Woman of childbearing potential; Population Group
T28	Age 730 741	edad fértil
T30	Neg_cue 762 764	no
T31	Duration 876 887	los 5 meses
T25	PROC 541 548	visitas
#24	AnnotatorNotes T25	C1512346; Patient Visit; Health Care Activity
T29	Neg_cue 495 497	no
T32	Observation 504 577	disponibles para completar todas las visitas o procedimientos del estudio
T33	Observation 617 665	cumplir con todos los procedimientos del estudio
A1	Population_data T27 Age
A2	Assertion T12 Negated
A3	Assertion T32 Negated
A4	Assertion T33 Negated
#25	AnnotatorNotes T5	C0005967; Bone neoplasms; Neoplastic Process 
R1	Overlap Arg1:T1 Arg2:T20	
R2	Experiences Arg1:T21 Arg2:T2	
R3	Location_of Arg1:T15 Arg2:T2	
R4	Location_of Arg1:T16 Arg2:T2	
R5	Experiences Arg1:T21 Arg2:T4	
R6	Used_for Arg1:T3 Arg2:T4	
R7	Location_of Arg1:T6 Arg2:T5	
R8	Location_of Arg1:T18 Arg2:T7	
R9	Location_of Arg1:T17 Arg2:T7	
T34	Quantifier_or_Qualifier 332 352	del estudio 20062004
T35	Observation 377 395	acepten participar
R11	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T34	
T36	Observation 414 427	firmen el ICF
#26	AnnotatorNotes T36	C0742766; consent signed; Finding
R13	Overlap Arg1:T35 Arg2:T36	
R14	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T32	
R15	Negation Arg1:T29 Arg2:T32	
R17	Negation Arg1:T29 Arg2:T33	
R18	Experiences Arg1:T24 Arg2:T8	
R19	Experiences Arg1:T24 Arg2:T10	
R20	Has_Age Arg1:T27 Arg2:T28	
R21	Negation Arg1:T30 Arg2:T12	
T38	Quantifier_or_Qualifier 808 824	altamente eficaz
A5	Assertion T38 Negated
R22	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T38	
T39	Observation 771 781	dispuestas
#29	AnnotatorNotes T39	C0600109; Willing; Finding
A6	Assertion T39 Negated
R23	Negation Arg1:T30 Arg2:T39	
R24	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T39	
R25	Experiences Arg1:T27 Arg2:T12	
R26	Overlap Arg1:T12 Arg2:T13	
R27	Experiences Arg1:T27 Arg2:T13	
R28	Experiences Arg1:T27 Arg2:T14	
R29	Has_Duration_or_Interval Arg1:T12 Arg2:T31	
R30	After Arg1:T12 Arg2:T14	
R31	Experiences Arg1:T27 Arg2:T11	
R32	Negation Arg1:T30 Arg2:T38	
R10	Overlap Arg1:T39 Arg2:T12	
#27	AnnotatorNotes T20	C0443252; Long-term; Temporal Concept
#28	AnnotatorNotes T35	C1302239; Patient consented to clinical trial; Finding
A7	Experiencer T21 Patient
A8	Experiencer T22 Patient
A9	Experiencer T23 Patient
A10	Experiencer T24 Patient
A11	Experiencer T26 Other
A12	Experiencer T27 Patient
